SCHEMBL1122912

SCHEMBL1122912

O=C(O)CCN(Cc1cccc(Oc2ccccc2)c1)C(=O)c1cccc(OCCN(Cc2ccccc2)Cc2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 3/20 0.49
PTGES O14684 3/20 0.49
LPAR5 Q9H1C0 2/20 0.47
F10 P00742 1/20 0.47
PPARG P37231 4/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
KMT2A Q03164 1/20 0.46
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SLC2A1 P11166 1/20 0.46
PPARA Q07869 3/20 0.44
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MEP1B Q16820 1/20 0.43
ALOX5 P09917 1/20 0.43
FFAR1 O14842 2/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1123244 0.93 LPAR1 (0.52) LPAR1PTGESLPAR5F10PPARG
SCHEMBL1123335 0.93 LPAR1 (0.52) LPAR1PTGESLPAR5PPARGKDM4E
SCHEMBL1123557 0.92 PTGES (0.52) PTGESF10PPARGKMT2ASLC2A1
SCHEMBL1123277 0.91 PPARG (0.49) LPAR1PTGESLPAR5F10PPARG
SCHEMBL1122385 0.89 PPARG (0.47) LPAR1F10PPARGKDM4EKMT2A
SCHEMBL1123395 0.89 F10 (0.51) LPAR1PTGESF10PPARGKMT2A
SCHEMBL1123247 0.88 SLC2A1 (0.47) LPAR1F10PPARGKMT2ASLC2A1
SCHEMBL1123394 0.87 KMT2A (0.52) PTGESF10PPARGKMT2AL3MBTL1
SCHEMBL1122952 0.86 LPAR1 (0.53) LPAR1LPAR5FFAR1
SCHEMBL1122692 0.86 LPAR1 (0.55) LPAR1PTGESLPAR5PPARGSLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG LPAR1 608/4885PTGES 110/4885LPAR5 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.